1. Home
  2. HRMY vs STRA Comparison

HRMY vs STRA Comparison

Compare HRMY & STRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HRMY
  • STRA
  • Stock Information
  • Founded
  • HRMY 2017
  • STRA 2017
  • Country
  • HRMY United States
  • STRA United States
  • Employees
  • HRMY N/A
  • STRA N/A
  • Industry
  • HRMY Biotechnology: Pharmaceutical Preparations
  • STRA Other Consumer Services
  • Sector
  • HRMY Health Care
  • STRA Real Estate
  • Exchange
  • HRMY Nasdaq
  • STRA Nasdaq
  • Market Cap
  • HRMY 1.6B
  • STRA 2.0B
  • IPO Year
  • HRMY 2020
  • STRA 1996
  • Fundamental
  • Price
  • HRMY $34.09
  • STRA $88.20
  • Analyst Decision
  • HRMY Strong Buy
  • STRA
  • Analyst Count
  • HRMY 8
  • STRA 0
  • Target Price
  • HRMY $52.88
  • STRA N/A
  • AVG Volume (30 Days)
  • HRMY 729.2K
  • STRA 240.5K
  • Earning Date
  • HRMY 05-06-2025
  • STRA 04-24-2025
  • Dividend Yield
  • HRMY N/A
  • STRA 2.72%
  • EPS Growth
  • HRMY 13.13
  • STRA 11.28
  • EPS
  • HRMY 2.62
  • STRA 4.68
  • Revenue
  • HRMY $744,852,000.00
  • STRA $1,233,270,000.00
  • Revenue This Year
  • HRMY $20.06
  • STRA $6.07
  • Revenue Next Year
  • HRMY $18.40
  • STRA $5.18
  • P/E Ratio
  • HRMY $12.76
  • STRA $18.85
  • Revenue Growth
  • HRMY 20.62
  • STRA 5.72
  • 52 Week Low
  • HRMY $26.47
  • STRA $74.28
  • 52 Week High
  • HRMY $41.61
  • STRA $123.41
  • Technical
  • Relative Strength Index (RSI)
  • HRMY 69.87
  • STRA 66.04
  • Support Level
  • HRMY $29.82
  • STRA $78.58
  • Resistance Level
  • HRMY $30.61
  • STRA $89.94
  • Average True Range (ATR)
  • HRMY 1.15
  • STRA 2.67
  • MACD
  • HRMY 0.71
  • STRA 1.20
  • Stochastic Oscillator
  • HRMY 98.91
  • STRA 86.54

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

About STRA Strategic Education Inc.

Strategic Education Inc. is an education services company that provides access to high-quality education through campus-based and online post-secondary education offerings, as well as through programs to develop job-ready skills for high-demand markets. The company operates through wholly-owned subsidiaries Strayer University and Capella University, both accredited post-secondary institutions of higher education located in the United States, as well as Torrens University, an accredited post-secondary institution of higher education located in Australia. It provide employees with access to affordable and industry relevant training, certificate, and degree programs. The reportable segments of the company are U.S. Higher Education, Australia/New Zealand and Education Technology Services.

Share on Social Networks: